Research Projects Page

This study evaluated prescription cannabidiol (CBD) outcomes including patient characteristics, adherence and discontinuation, and clinical outcomes during the first 12 months of therapy. Patients initiating therapy had complex medication use patterns. Adherence was high (PDC 94%), but 23% of patients discontinued in the first 12 months. Many patients (37%) utilized emergency healthcare services after CBD initiation. There was no significant change in concomitant ASM use.

This study evaluated the rate and reasons for Primary Medication Nonadherence (PMN) to specialty oral oncology medications in Health System Specialty Pharmacies (HSSP). Multisite retrospective cohort study across 7 HSSP sites. Most patients (89%) prescribed oral oncology treatment at HSSP initiated therapy. Primary medication nonadherence was mostly due to patient decision.

This study assessed the appropriateness of the chronic inhaler regimen for patients admitted to the hospital based on clinical practice guidelines and insurance coverage.

This study evaluated reasons for and rates of primary medication nonadherence to specialty DMARDs in patients with RA referred to an integrated health systems specialty pharmacy

This podium presentation discusses experiences in liver transplantation and the management of HCV into opportunity for successful donor expansion.

This study evaluated the out-of-pocket (OOP) costs of LCPT vs IR-Tac in kidney transplant patients, including the use of financial assistance, and found that at an institution with patient assistance grants, patients are less likely to have high out of pocket costs with LCPT compared to those prescribed IR-Tac.

This Viewpoint paper describes programs that employers, health plans, and other payers are using to reduce their own spending on specialty drugs including copay accumulator and maximizer programs and alternative funding programs.

The objective of this study was to evaluate the implementation of a dashboard to prevent therapy gaps by prospectively identifying patients on biologic therapy needing a new prescription with outdated labs. The new dashboard was highly effective at reducing the number of patients with a therapy gap, number of gap days, and days to receipt of a new prescription. Pharmacists and nurses reported high satisfaction rates with the new dashboard.

Because MedB billing error fines can be costly for pharmacies dispensing high-cost medications, identifying common errors and training staff can be useful and financially prudent. The aim of this quality improvement project was to retrain certified pharmacy technicians (CPhTs) on common monthly billing errors and evaluate changes in error rates and potential fines.

This randomized prospective study evaluated the effectiveness pharmacist interventions had on specialty medication adherence using proportion of days covered (PDC). After 8 months post-enrollment, median PDC in the intervention group was significantly higher than the control group. Currently, 3 products related to this research are below: